Is glycated haemoglobin a sensitive index to identify left ventricular dysfunction two months after acute myocardial infarction in normotensive subjects?

International Journal of Cardiology

Volumn 110, Issue 1, 2006, Pages 67-73

  Salmasi, Abdul Majeed ^a   Frost, Peter ^b   Dancy, Mark ^a  

^a Cardiology Department   (United Kingdom)

^b CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Diastolic function; HbA1c; Impaired glucose tolerance; Mellitus; Myocardial infarction; Systolic function

Indexed keywords

CREATINE KINASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HUMAN; ISOMETRIC EXERCISE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PARAMETER; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; BLOOD PRESSURE; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33646595290     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.08.008     Document Type: Article

References (47)

1. Coutinho M., Gerstein H., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. Diabetes Care 22 (1999) 233-240
2. 1c values. Arch Intern Med 164 (2004) 1627-1632
3. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41 (1992) 202-208
4. Vitelli L.L., Shahar E., Heiss G., et al. Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The atherosclerosis risk in communities study. Diabetes Care 20 (1997) 1454-1458
5. Kessler I. Mortality experience of diabetic patients. Am J Med 51 (1971) 715-724
6. Kannel W., and McGee D. Diabetes and cardiovascular disease: the Framingham study. JAMA 241 (1979) 2035-2038
7. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Coronary heart disease risk and impaired glucose tolerance: the Whitehall study. Lancet I (1980) 1373-1376
8. Abbud Z.A., Shindler D.M., Wilson A.C., and Kostis J.B. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Am Heart J 130 (1995) 51-58
9. Malmberg K., and Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9 (1988) 105-111
10. Battler A., Slutsky R., Karliner J., Ashburn W., and Ross J. Ejection fraction early after acute myocardial infarction as a predictor of mortality and morbidity. Am J Cardiol 43 (1979) 371
11. Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Eng J Med 309 (1983) 331-336
12. Ferguson D.W., White C.W., Schwartz J.L., et al. Influence of baseline ejection fraction and success of thrombolysis on mortality and ventricular function after acute myocardial infarction. Am J Cardiol 54 (1984) 705-711
13. Fujii J., Yazaki Y., Sawada H., Aizawa T., Watanabe H., and Kato K. Noninvasive assessment of left and right ventricular filling in myocardial infarction with a two-dimensional Doppler echocardiographic method. Am J Cardiol 5 (1985) 1155-1160
14. Johannessen K.A., Cerqueria M.D., and Stratton J.R. Influence of myocardial infarction size on radionuclide and Doppler echocardiographic measurements of diastolic function. Am J Cardiol 65 (1990) 692-697
15. Poulsen S.H., Jensen S.E., and Egstrup K. Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction. Am Heart J 137 (1999) 910-918
16. Lee H.-o., Eisenberg M.J., and Schiller N.B. Serial assessment of left ventricular function after myocardial infarction. Am Heart J. 130 (1995) 999-1002
17. Liu J.E., Palmieri V., Roman M.J., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the strong heart study. J Am Coll Cardiol 37 (2001) 1943-1949
18. Vecht R.J. The grip test: a simple method for the assessment of left ventricular performance. Eur J Cardiol 4 (1976) 335-347
19. Hughes L.O., Raval U., and Raftery E.B. First myocardial infarctions in Asians and white men. Br Med J 298 (1989) 1345-1350
20. Nishimura R.A., and Tajik J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's rosetta stone. J Am Coll Cardiol 30 (1997) 8-18
21. Poulsen S.H., Jensen S.E., Moller J.E., and Egstrup K. Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction. Heart 86 (2001) 376-380
22. Byrd B.F., Finkbeiner W., Bouchard A., Silverman N.H., and Schiller N.B. Accuracy and reproducibility of clinically acquired two-dimensional echocardiographic mass measurements. Am Heart J 117 (1989) 133-137
23. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
24. Folland E.D., Parisi A.F., Moynihan P.F., Jones D.R., Feldman C.L., and Tow D.E. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 60 (1979) 760-766
25. Stratton I., Adler A., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321 (2000) 405-412
26. Report of the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 Diagnosis and Classification of Diabetes Mellitus (1999), World Health Organisation, Geneva
27. American diabetes association. Tests of glycemia in diabetes. Diabetes Care 25 suppl. 1 (2002) S97-S99
28. American diabetes association. Screening for type 2 diabetes (position statement). Diabetes Care 22 suppl. 1 (1999) S20-S23
29. 1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23 (2000) 187-191
30. Bur A., Herkner H., Woisetschlager C., Vlcek M., Derhaschnig U., and Hirschi M.M. Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?. Am J Hypertens 16 (2003) 297-301
31. Khaw K.T., Wareham N., Luben R., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Br Med J 322 (2001) 1-6
32. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of completions in patients with type 2 diabetes (UKPDS33). Lancet 352 (1998) 837-853
33. Holzmann M., Olsson A., Johansson J., and Jensen-Urstad M. Left ventricular diastolic function is related to glucose in a middle-aged population. J Intern Med 251 (2002) 415-420
34. Diamant M., Lamb H.J., Groeneveld Y., et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42 (2003) 328-335
35. Fein F.S., and Sonnenblick E.H. Diabetic cardiomyopathy. Prog Cardiovasc Dis 27 (1985) 255-270
36. van Hoeven K.H., and Factor S.M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990) 848-855
37. Mizushige K., Yao L., Noma T., et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101 (2000) 899-907
38. Miyazato J., Horio T., Takishita S., and Kawano Y. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension. Hypertens Res 25 (2002) 403-409
39. Fein F., and Scheuer J. Heart disease in diabetes mellitus: theory and practice. In: Rifkin H., and Porte Jr. D. (Eds) (1990), Elsevier, New York 812-823
40. Robertson W., and Strong J. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest 18 (1968) 538-551
41. Jacoby R., and Nesto R.W. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 20 (1992) 736-744
42. Zarich S.W., Arbuckle B.E., Cohen L.R., Roberts M., and Nesto R.W. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 12 (1988) 114-120
43. Califf R.M. Insulin resistance: a global epidemic in need of effective therapies. Eur Heart J 5 (2003) C13-C18
44. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes Care 22 (1999) 920-924
45. Mannucci E., Ognibene A., Sposato I., et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 40 (2003) 181-186
46. Miyazato J., Horio T., Takishita S., and Kawano Y. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension. Hypertens Res 25 (2002) 403-409
47. de Vegt F., Dekker J.M., Ruhe H.G., et al. Hyperglycemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931